Deborah Schiff
Pediatric Hematology-Oncology · San Diego, CANPI 1922179779
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,112 of the $3,357 with a category attached, or 62.9%. 6 manufacturers reported payments, led by Adaptive Biotechnologies Corporation at 50.0% of the total. Reporting peaked in 2023 at $1,680 and has fallen 87.9% since, to $203 in 2025.
Across 20 payments — averaging $167.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Adaptive Biotechnologies Corporation$2K
- Novartis$1K
- Jazz Pharmaceuticals Inc.$244
- Incyte Corporation$221
- Genetix Biotherapeutics Inc$97
- Servier Pharmaceuticals LLC$38
Across 12 payments — averaging $45,669 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$482K
- Novartis$66K
What the payments were for
- Consulting fees$1113%
- Travel & lodging$2,11263%
- Food & beverage$1,13434%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Adaptive Biotechnologies Corporation | 4 | $1,680 |
| Novartis | 9 | $1,079 |
| Jazz Pharmaceuticals Inc. | 2 | $244 |
| Incyte Corporation | 2 | $221 |
| Genetix Biotherapeutics Inc | 1 | $97 |
| Servier Pharmaceuticals LLC | 2 | $38 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,357 in reported general payments places this provider in the 65th percentile of 307 pediatric hematology-oncology providers in California.
See all pediatric hematology-oncology providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other pediatric hematology-oncology in San Diego
- Courtney ThornburgSan Diego$132K
- Julie JaffraySan Diego$90K
- Jennifer YuSan Diego$19K
- Hilda DingSan Diego$17K
- Philip PizzoPalo Alto$2.6M
- Vinod BalasaMadera$508K
- Akshat JainRedlands$447K
- Noah FedermanLos Angeles$399K
- Vanessa Salinas-LunaOrange$344K
- Daniel KraftStanford$294K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.